Driven.
For Quality.

Samsung Biologics is committed to upholding the highest quality standards by ensuring that all CGxP processes comply with global regulatory guidelines and industry expectations.

Quality System
With a centralized and unified Quality team, we take end-to-end responsibility for quality across all of our facilities.
Our comprehensive Quality System is enhanced by digitalization, enabling proactive quality management. We have an established training program, which guarantees that any personnel involved in CGMP operations are qualified to do so.
  • EQUIS

    Enterprise Quality Unified
    Information System

    Electronic Quality Management System (eQMS) encompassing quality event management, change control and documentation management
  • LMS

    Learning
    Management System

    Management system for employee training, certification, and personal qualification
  • LIMS

    Laboratory Information
    Management System

    Integrated system for 24/7 management of laboratory data and QC testing activities
Samsung Biologics leverages AI-driven platforms to better adapt to the changing regulatory landscape, streamline quality assurance, and improve manufacturing processes.
Quality Culture
The Quality Unit functions independently from Operations to ensure that all CGMP processes comply with regulatory guidelines and industry expectations. The team is structured across Quality Control (QC), which ensures rigorous analytical testing and compliance, and Quality Assurance (QA), which oversees process integrity and regulatory standards. Along with a dedicated Regulatory Affairs team, we ensure the quality, safety, and efficacy of your products from development to IND/IMPDs, BLA/MAAs, and beyond.
  • Quality Control
    • Testing Operations
    • Method Transfer & Optimization
    • Facility Monitoring
    • Sample Management
    • Stability Programs
  • Quality Assurance
    • Facility Oversight
    • Training & Quality Systems
    • Analytical & Development Oversight
    • Audit & Inspection Management
    • Data Governance
  • Regulatory Affairs
    • Preparation of Common Technical Document
    • Response to Questions
    • Regulatory Strategy & Consulting
    • Regulatory Intelligence
  • 0
    Regulatory approvals
    (FDA, EMA, PMDA, etc.)
  • 99%
    Batch Success Rate

Related Content

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION